Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 1608-1612, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgan, B. R.
Right arrow Articles by Zak, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, B. R.
Right arrow Articles by Zak, B.

Clinical Chemistry, Vol 39, 1608-1612, Copyright © 1993 by American Association for Clinical Chemistry

Calcium determination in serum with stable alkaline Arsenazo III and triglyceride clearing

BR Morgan, JD Artiss and B Zak
Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201.

We describe an analytical procedure for determining serum calcium, using the ligand Arsenazo III in an aqueous alkaline medium. The choice of pH for the proposed technique differs from current procedures, which are for the most part carried out in a slightly acidic medium. An acidic medium avoids interference from magnesium, but is spectrophotometrically suboptimal for this pH-dependent reaction: the molar absorptivity of the Arsenazo III complex with calcium at acid pH is 13,787 L mol-1 cm-1, about one-half of that at a more optimal alkaline pH (26,574 L mol-1 cm-1). We have included a clearing technique in the reagent to avoid spectral aberrations from hypertriglyceridemic samples. alpha-Cyclodextrin absorbs the nonesterified fatty acids liberated from triglycerides by a microbial lipase. This modification may also be helpful for binding nonesterified fatty acids, which are known to interfere with calcium procedures by forming calcium soaps and thus preventing the reaction with intended ligands. The use of 8-hydroxyquinoline sulfonate as the magnesium- masking agent facilitates the use of alkaline pH. The less-water- soluble alternative, 8-hydroxyquinoline, commonly used as a precipitating agent for several methods, is difficult to solubilize in the alkaline reagent and tends to precipitate when complexed to magnesium. Finally, the use of alkaline pH results in a prolonged (> or = 6 weeks) shelf life for the reagent.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
E. Hokazono, S. Osawa, T. Nakano, Y. Kawamoto, Y. Oguchi, T. Hotta, Y. Kayamori, D. Kang, Y. Cho, K. Shiba, et al.
Development of a new measurement method for serum calcium with chlorophosphonazo-III
Ann Clin Biochem, July 1, 2009; 46(4): 296 - 301.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.